Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by H. Lee Moffitt Cancer Center and Research Institute
Sponsor:
Collaborators:
Bristol-Myers Squibb
Medarex
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute
ClinicalTrials.gov Identifier:
NCT01176461
First received: August 5, 2010
Last updated: July 10, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2015
  Estimated Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)
No publications provided by H. Lee Moffitt Cancer Center and Research Institute

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):